Holds oil and gas royalty interests that earn payments from well operators, and invests in energy companies and gold.
10-K for FY2025, filed Apr 15, 2026The Company’s three (3) fractional royalty interests entitle the Company to receive a proportional share of revenues generated from the…View ↗
In the public arena, the Company is opportunistic and maintains its diverse operating and investment activities. These included the…View ↗
The Company also maintains a gold investment and short-term treasury exchange-traded funds for the purpose of facilitating investment into…View ↗
Mentor earns royalties from oil and gas production: producers owe payments once production occurs, and the company estimates income in the month oil is produced, adjusting it when payments arrive.
10-K for FY2025, filed Apr 15, 2026The Company’s three (3) fractional royalty interests entitle the Company to receive a proportional share of revenues generated from the…View ↗
Accrued royalty income and incurred severance taxes are estimated and recognized in the month oil is produced, when royalty income is…View ↗
In March 2025, the Company acquired three fractional, non-operating royalty interests in oil and gas properties covering approximately one…View ↗
$166.8K
10-K for FY2025, filed Apr 15, 2026
$166.8K ↗
Well operators and producers send royalty payments to Mentor for its interests in oil and gas properties.
10-K for FY2025, filed Apr 15, 2026
No. It lost $574.1K in FY2025.
10-Q for Q2 FY2026, filed Aug 13, 2026
−$202.3KView ↗
8-K, filed Apr 23, 2026
On April 20, 2026, the Company dismissed its independent accountant, Cherry Bekaert LLP (“Cherry Bekaert”). The dismissal was approved by…View ↗
Shrinking. Revenue fell 97% in 4 years, from $6M in FY2021 to $166.8K in FY2025, about 59% a year.
Investment focus
The older report described target sectors including energy, manufacturing, and management services; the latest emphasizes classic energy and describes gold and precious-metals trading.
10-K for FY2022, filed Mar 28, 2023 10-K for FY2025, filed Apr 15, 2026In 2009, the Company began focusing its investing activities in leading-edge cancer companies. In early 2013, in response to government…View ↗
Loading...